InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (5 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
5
T+90 hit rate
14%
T+90 mean return
-19.6%
Across 7 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the complete record of transactions filed by HILLEMAN JERYL L, Director. Insider active across 3 companies, notably Omada Health, Inc.. Cumulatively, 17 disclosures have been published. Breakdown: 0 buy · 5 sells. Total volume traded: €355k. Activity tracked since 9 June 2021. The latest transaction was filed on 5 July 2026 (Attribution). Regulator: SEC (Form 4). All data is free.
Declarations17 total
1,299 shares0Common StockSEC:0001610717-26-000324:0
10,957 shares0Common stockSEC:0001216628-26-000003:0
1,081 shares0Common StockSEC:0001610717-25-000425
1,081 shares0Common StockSEC:0001610717-25-000425:0
8,791 shares0Common StockSEC:0001562180-24-005327:0
4,053 shares0Restricted Stock UnitsSEC:0001562180-24-004749:0
2,081 shares@ US$28.7416.6% of flowCommon StockSEC:0001562180-23-005383:0
4,866 shares0Common StockSEC:0001562180-23-005110:0
8,324 shares0Common StockSEC:0001562180-22-005231:0
407 shares@ US$69.610.0018% mcap100.0% of flowOrdinary SharesSEC:0001645113-22-000057:0
1,924 shares@ US$13.80560.0041% mcap9.3% of flowCommon StockSEC:0001562180-22-005093:0
4,400 shares@ US$33.710.020% mcap45.3% of flowCommon StockSEC:0001562180-21-004532:0
4,400 shares@ US$33.7137.8% of flowCommon StockSEC:0001562180-21-004532
3,848 shares0Common StockSEC:0001562180-21-004254
3,848 shares0Common StockSEC:0001562180-21-004254:0
814 shares0Restricted Stock UnitsSEC:0001645113-21-000076
814 shares0Restricted Stock UnitsSEC:0001645113-21-000076:0
17 of 17 declarations
About HILLEMAN JERYL L
HILLEMAN JERYL L serves as a Director at Omada Health, Inc., NovoCure Ltd, and SI-BONE, Inc. In this role, he contributes to the governance and strategic direction of these companies. His experience in the healthcare sector allows him to provide valuable insights on growth and innovation opportunities. Jeryl plays a key role in overseeing operations and evaluating company performance.
